Advertisement

Ads Placeholder
Loading...

Novartis AG

NVS•NYSE
Healthcare
Drug Manufacturers - General
$154.03
$-1.05(-0.68%)
U.S. Market opens in 3h 58m

Novartis AG (NVS) Stock Overview

Explore Novartis AG’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap297.8B
P/E Ratio21.07
EPS (TTM)$7.15
ROE0.33%
Fundamental Analysis

AI Price Forecasts

1 Month$151.91
3 Months$188.44
1 Year Target$163.60

NVS Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Novartis AG (NVS) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $163.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 21.07 and a market capitalization of 297.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.68%
5-Day Change
2.68%
1-Month Change
-6.18%
3-Month Change
11.18%
6-Month Change
16.35%
Year-to-Date (YTD) Change
11.18%
1-Year Change
37.21%
3-Year Change
75.93%
5-Year Change
86.52%
All-Time (Max) Change
879.21%

Contact Information

https://www.novartis.com
41 61 324 1111
Lichtstrasse 35, Basel, NaN, 4056

Company Facts

758,830 Employees
IPO DateNov 7, 1996
CountryCH
Actively Trading

Frequently Asked Questions